Business in the Burbs

Acorda submits drug application

February

Acorda Therapeutics Inc. of Hawthorne said this morning it has submitted an application to market Fampridine-SR, a treatment to help people with multiple sclerosis walk. The company said it believes that if the U.S. Food and Drug Administration accepts the application for review, the FDA could complete its review within 10 months.

The company said at least 400,000 people in the United States have multiple sclerosis and studies show at least 64 percent of those have trouble walking. Many people with the condition say that walking is the biggest challenge it poses, the company said.

Acorda said it has also discussed the drug with regulators in Europe and it plans to file an application there.

This entry was posted on Monday, February 2nd, 2009 at 10:47 am by Allan Drury. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical

Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.